February 15, 2025

BRANFORD, Conn.–(BUSINESS WIRE)–Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year ended December 31, 2023, and provided a business update.

FY 2023 and Recent Business Highlights

Leave a Reply

Your email address will not be published. Required fields are marked *